ASBP

Aspire Biopharma Holdings, Inc. Common Stock

21 hedge funds and large institutions have $17.9M invested in Aspire Biopharma Holdings, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
Holders Change %
0%
% of All Funds
0.31%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
3
Increased
3
Reduced
5
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
FTCM
1
Fir Tree Capital Management
New York
$1.97M +$376K +34,462 +24%
PC
2
Periscope Capital
Ontario, Canada
$1.91M -$284K -26,050 -13%
AI
3
Arena Investors
New York
$1.64M
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$1.64M
AA
5
AQR Arbitrage
Connecticut
$1.64M
ETH
6
Exos TFP Holdings
New York
$1.63M
LP
7
LMR Partners
United Kingdom
$1.63M
PSAMP
8
P. Schoenfeld Asset Management (PSAM)
New York
$1.45M
FTCM
9
First Trust Capital Management
Illinois
$1.4M
RCM
10
Radcliffe Capital Management
Pennsylvania
$1.11M +$5.34K +490 +0.5%
SCM
11
Shaolin Capital Management
Florida
$689K -$218K -20,000 -24%
WCMNY
12
Westchester Capital Management (New York)
New York
$393K
GCL
13
Glazer Capital LLC
New York
$334K +$334K +30,639 New
TCM
14
Tuttle Capital Management
Connecticut
$185K +$185K +17,000 New
RCM
15
Robinson Capital Management
Michigan
$114K -$8.36K -768 -7%
TI
16
Tidal Investments
Wisconsin
$114K -$8.38K -768 -7%
QL
17
Quarry LP
New York
$13.1K +$10.1K +928 +341%
SOA
18
Sea Otter Advisors
Florida
$12.2K -$3.62K -332 -23%
BlackRock
19
BlackRock
New York
$3.27K +$3.27K +300 New
EC
20
Elequin Capital
New York
$109
MSU
21
Mizuho Securities USA
New York
-$376K -35,000 Closed
UBS Group
22
UBS Group
Switzerland
-$650 -60 Closed
TRCT
23
Tower Research Capital (TRC)
New York
-$87 -8 Closed